| Bacillus subtilis |
Bacillus subtilis |
MIC |
6300.0 |
nM |
None |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.01033-06 |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.01033-06 |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.01033-06 |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.01803-09 |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.01033-06 |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.01033-06 |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
1024.0 |
ug.mL-1 |
10.1128/aac.01803-09 |
| Burkholderia pseudomallei |
Burkholderia pseudomallei |
MIC |
2048.0 |
ug.mL-1 |
10.1128/aac.01803-09 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Chlamydia trachomatis |
Chlamydia trachomatis |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.0c00371 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
nan |
None |
None |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1016/j.bmcl.2013.02.005 |
| Escherichia coli |
Escherichia coli |
IC50 |
990.0 |
nM |
10.1021/acs.jmedchem.8b00790 |
| Escherichia coli |
Escherichia coli |
MIC |
0.512 |
ug.mL-1 |
10.1016/j.ejmech.2022.114108 |
| Escherichia coli |
Escherichia coli |
MIC |
0.8533 |
ug.mL-1 |
10.1016/j.ejmech.2022.114108 |
| Escherichia coli |
Escherichia coli |
MIC |
4.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Escherichia coli |
Escherichia coli |
MIC |
5.6 |
ug.mL-1 |
10.1021/acs.jmedchem.7b00204 |
| Escherichia coli |
Escherichia coli |
MIC |
6.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Escherichia coli |
Escherichia coli |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Escherichia coli |
Escherichia coli |
MIC |
12.5 |
ug.mL-1 |
10.1128/aac.00719-10 |
| Escherichia coli |
Escherichia coli |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Escherichia coli |
Escherichia coli |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Escherichia coli |
Escherichia coli |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00926-07 |
| Escherichia coli |
Escherichia coli |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.01472-06 |
| Escherichia coli |
Escherichia coli |
MIC |
20.0 |
ug.mL-1 |
10.1128/aac.00779-06 |
| Escherichia coli |
Escherichia coli |
MIC |
25.0 |
ug.mL-1 |
10.1128/aac.00719-10 |
| Escherichia coli |
Escherichia coli |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Escherichia coli |
Escherichia coli |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Escherichia coli |
Escherichia coli |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.00926-07 |
| Escherichia coli |
Escherichia coli |
MIC |
300.0 |
ug.mL-1 |
10.1128/aac.00779-06 |
| Escherichia coli |
Escherichia coli |
MIC |
nan |
None |
None |
| Escherichia coli |
Escherichia coli |
MIC90 |
20.0 |
ug.mL-1 |
10.1016/j.bmcl.2009.11.042 |
| Escherichia coli (strain K12) |
30S ribosomal protein S18 |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Escherichia coli (strain K12) |
tRNA threonylcarbamoyladenosine biosynthesis protein TsaE |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-46.51 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.49 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Telomerase reverse transcriptase |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2004.04.055 |
| Homo sapiens |
Telomerase reverse transcriptase |
Inhibition |
nan |
% |
10.1016/j.bmcl.2004.04.055 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella aerogenes |
Klebsiella aerogenes |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Klebsiella aerogenes |
Klebsiella aerogenes |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Activity |
nan |
None |
10.1128/aac.00710-10 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Mus musculus |
Mus musculus |
LD50 |
10000.0 |
mg.kg-1 |
10.1016/j.bmcl.2017.05.013 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
FC |
2.0 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
FC |
4.0 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
FC |
16.0 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
FICI |
0.19 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
FICI |
0.31 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
FICI |
0.63 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
32.0 |
ug.mL-1 |
10.1021/np3006277 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC99 |
5.25 |
uM |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC99 |
10.52 |
uM |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC99 |
21.04 |
uM |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC99 |
42.05 |
uM |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC99 |
84.12 |
uM |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC99 |
84.12 |
uM |
10.1039/C3MD00387F |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
Ratio |
0.062 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
Ratio |
0.5 |
None |
10.1016/j.bmc.2014.06.012 |
| Mycoplasma putrefaciens |
Mycoplasma putrefaciens |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00420-07 |
| Mycoplasma putrefaciens |
Mycoplasma putrefaciens |
MIC50 |
16.0 |
ug.mL-1 |
10.1128/aac.00420-07 |
| Mycoplasma putrefaciens |
Mycoplasma putrefaciens |
MIC90 |
16.0 |
ug.mL-1 |
10.1128/aac.00420-07 |
| Mycoplasma putrefaciens |
Mycoplasma putrefaciens |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00420-07 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
Activity |
0.0 |
% |
10.1128/aac.00788-10 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
Activity |
100.0 |
% |
10.1128/aac.00788-10 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00198-08 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00198-08 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
MIC50 |
32.0 |
ug.mL-1 |
10.1128/aac.00788-10 |
| Neisseria gonorrhoeae |
Neisseria gonorrhoeae |
MIC90 |
32.0 |
ug.mL-1 |
10.1128/aac.00788-10 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Pasteurella multocida |
Pasteurella multocida |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00229-07 |
| Pasteurella multocida |
Pasteurella multocida |
MIC |
4096.0 |
ug.mL-1 |
10.1128/aac.00229-07 |
| Pasteurella multocida |
Pasteurella multocida |
MIC |
8192.0 |
ug.mL-1 |
10.1128/aac.00229-07 |
| Proteus vulgaris |
Proteus vulgaris |
MIC |
1.25 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Proteus vulgaris |
Proteus vulgaris |
MIC |
125.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
2.5 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
250.0 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
512.0 |
ug.mL-1 |
10.1128/aac.00710-10 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.01472-06 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.00079-09 |
| Serratia marcescens |
Serratia marcescens |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Serratia marcescens |
Serratia marcescens |
MIC |
15.6 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Shigella flexneri |
Shigella flexneri |
MIC |
7.8 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Shigella flexneri |
Shigella flexneri |
MIC |
7.8 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
31.2 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
31.25 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00247-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.01091-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
128.0 |
ug.mL-1 |
10.1016/j.bmc.2010.02.005 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
25000.0 |
nM |
None |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
50000.0 |
nM |
None |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
800000.0 |
nM |
None |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
nan |
None |
10.1128/aac.01472-06 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC |
6300.0 |
nM |
None |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC |
nan |
None |
None |
| Streptococcus pyogenes |
Streptococcus pyogenes |
MIC |
12500.0 |
nM |
None |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
Activity |
8.31 |
% |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
Activity |
59.0 |
% |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
Activity |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
IZ |
20.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
IZ |
31.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces alboniger |
Streptomyces alboniger |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces alboniger |
Streptomyces alboniger |
IZ |
35.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
Activity |
0.8 |
% |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
Activity |
1.1 |
% |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
Activity |
5.01 |
% |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
11.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
19.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
27.0 |
mm |
10.1584/jpestics.28.183 |
| None |
ADMET |
C50 |
10.0 |
uM |
10.1021/jm00385a015 |
| None |
ADMET |
CL |
0.99 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
MRT |
2.2 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
NA |
nan |
None |
10.1021/jm00385a015 |
| None |
ADMET |
T1/2 |
1.8 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.13 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Nucleic Acid |
Kd |
100000.0 |
nM |
10.1016/j.bmcl.2011.12.103 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/mp100103e |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
752220.0 |
nM |
10.1016/j.bmcl.2017.05.013 |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmc.2015.07.062 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
0.0 |
% |
10.1016/j.bmcl.2004.04.055 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2015.07.062 |
| None |
Unchecked |
Kd |
nan |
None |
10.1016/j.bmc.2015.07.062 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
MIC |
31.2 |
ug.mL-1 |
10.1016/j.ejmech.2020.112768 |
| None |
Unchecked |
MIC |
31.25 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.013 |
| None |
Unchecked |
Time |
nan |
None |
10.1128/aac.00620-10 |
| None |
Unchecked |
TIME |
0.005556 |
hr |
10.1128/aac.00620-10 |